Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment.
Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment. Proc Natl Acad Sci U S A. 2015 Jun 23; 112(25):7779-84.